Journey Together went on sale on March 28, 2025 and Destined Rivals nine weeks later on May 30. Both are Scarlet and Violet sets, both have a complete catalog on our tape from their own release day, and both are measured the same way here: the sum of every card we price in the set. Destined Rivals reads $1,750.98 and Journey Together $478.17, a ratio of 3.66 to 1. The reasonable first guess is that one huge card is doing the work in Destined Rivals. The data says something more boring and more useful: the gap is roughly the same size at every level of both sets, which means the difference is not concentration risk, it is demand.
The top five, side by side
Top five cards by market price
| # | Destined Rivals | Price | Journey Together | Price |
|---|---|---|---|---|
| 1 | Team Rocket's Mewtwo ex | $445.87 | Lillie's Clefairy ex | $101.93 |
| 2 | Cynthia's Garchomp ex | $230.39 | Salamence ex | $56.73 |
| 3 | Ethan's Ho-Oh ex | $152.63 | N's Zoroark ex | $46.19 |
| 4 | Team Rocket's Nidoking ex | $97.39 | Iono's Bellibolt ex | $38.13 |
| 5 | Team Rocket's Moltres ex | $94.20 | Hop's Zacian ex | $30.43 |
| Total | $1,020.48 | $273.41 |
So the headline instinct is right about the chase. Team Rocket's Mewtwo ex is 4.37 times Lillie's Clefairy ex, and the Destined Rivals second card, Cynthia's Garchomp ex at $230.39, is worth more than the top two Journey Together cards put together. Where the instinct goes wrong is in what that implies about the rest of the set.
Concentration is not the difference
Where each set keeps its value
The same split as ratios
| Slice | Destined Rivals | Journey Together | Ratio |
|---|---|---|---|
| Top 5 cards | $1,020.64 | $273.56 | 3.73x |
| Cards 6 to 10 | $243.11 | $81.52 | 2.98x |
| Everything else | $487.23 | $123.09 | 3.96x |
| Whole set | $1,750.98 | $478.17 | 3.66x |
| Median priced card | $0.21 | $0.16 | 1.31x |
| Priced cards | 256 | 198 | 1.29x |
Read down the ratio column. If Destined Rivals were a one-card set with a long worthless tail, the top-five ratio would be far above the whole-set ratio and the tail ratio far below it. Instead the widest gap, 3.96x, is in the cards outside the top ten, and the narrowest, 2.98x, is in cards six to ten. The premium is spread across the set rather than parked on the chase, and the concentration figures say the same thing: 58.3% against 57.2% in the top five, and 72.2% against 74.3% in the top ten, where Journey Together is actually the more concentrated of the two.
Which gives the cleanest way to say how far apart these two sets are. The 246 Destined Rivals cards outside its top ten are worth $487.23. Every priced card in Journey Together, all 198 of them including Lillie's Clefairy ex, is worth $478.17. The part of Destined Rivals nobody talks about is worth slightly more than the whole of the other set.
The two sets have had opposite histories
Measured from each set's own release date
| Destined Rivals | Journey Together | |
|---|---|---|
| Released | May 30, 2025 | March 28, 2025 |
| First reading after release | $1,898.13 | $995.68 |
| Highest post-release reading | $2,481.48 on day 122 | $995.68 on day 3 |
| Floor | $1,571.33, Jan 19, 2026 | $456.39, Jan 17, 2026 |
| Most recent rally high | $2,258.36, Jun 14, 2026 | $600.60, May 24, 2026 |
| Today | $1,750.98 | $478.17 |
| Against the release price | -7.8% | -52.0% |
| Readings at or above the release price | 154 of 312 | 1 of 321 |
| Last reading above the release price | July 26, 2026 | March 31, 2025 |
| Percentile of its own post-release history | 26th | 10th |
Journey Together set its highest post-release price on the third day it was on sale and has never come back to it in the 535 days since. The single reading at or above its release price is the baseline reading itself. Destined Rivals took 122 days to peak, spent roughly half of its recorded life at or above what it opened at, and was still above the release price as recently as July 26, 2026. They bottomed within two days of each other in January, which is the one thing the two sets clearly share, and which suggests the January low was a market event rather than a set event.
That is the substance behind the price gap. It is not that Destined Rivals had a bigger card. It is that Destined Rivals held a bid and Journey Together did not, and the bid shows up at every level of the set at once. More detail on the Destined Rivals path, including why the release-date baseline is the only honest one to use here, is in Destined Rivals Is 7.8% Below Its Release Price, and It Was 10% Cheaper in January.
The last three weeks, at card level
Our daily card-level tape runs 22 days. Over that window Destined Rivals had 65 lines priced at $1 or more on the first day, of which 18 rose, 2 were flat and 45 fell. Journey Together had 35 such lines, of which 10 rose, 1 was flat and 24 fell. Both sets are selling off in much the same proportion, at roughly 70% of lines down. Two of those lines, one in each set, have no entry in our card catalog and so appear in the counts but not in the table below; the Journey Together one ran from $4.58 to $6.50, which makes it the largest gainer in either set.
Notable 22-day moves, cards priced at $1 or more, both sets
| Set | Card | Three weeks ago | Latest | Move |
|---|---|---|---|---|
| Journey Together | Blaziken ex | $2.36 | $1.19 | -49.6% |
| Journey Together | N's Zoroark ex | $1.72 | $1.21 | -29.7% |
| Journey Together | Salamence ex | $2.13 | $1.57 | -26.3% |
| Destined Rivals | Cynthia's Roserade | $14.24 | $11.07 | -22.3% |
| Destined Rivals | Team Rocket's Houndoom | $13.01 | $10.69 | -17.8% |
| Journey Together | Wailord | $15.14 | $13.08 | -13.6% |
| Destined Rivals | Team Rocket's Mewtwo ex | $1.57 | $1.95 | +24.2% |
| Journey Together | Iono's Bellibolt ex | $1.69 | $2.03 | +20.1% |
| Destined Rivals | Team Rocket's Giovanni | $5.13 | $6.15 | +19.9% |
| Journey Together | Articuno | $19.63 | $20.98 | +6.9% |
The same ranking, at half the multiple
Sealed listing prices, with their own 30-day change
| Product | Destined Rivals | 30d | Journey Together | 30d |
|---|---|---|---|---|
| Booster box | $431.62 | +4.4% | $239.55 | -19.9% |
| Booster box case | $2,605.91 | -6.7% | $1,712.80 | -5.4% |
| Elite Trainer Box | $113.52 | -5.4% | $139.21 | +4.0% |
| Booster bundle | $65.29 | -5.8% | $46.23 | +0.4% |
On boxes the gap is 1.80x rather than 3.66x, which is what you would expect if singles carry the set premium and sealed carries mostly print run. One caution on the Journey Together box: the plain booster box is down 19.9% over 30 days while the Enhanced Booster Box at $252.17 is up 1.2% and the Half Booster Box at $333.33 is unchanged. Three SKUs of the same product disagreeing that sharply usually means a listing mix moved rather than the market, so the 19.9% should not be leaned on.
The cleanest single comparison in the whole piece is the chase against the box it comes out of. Team Rocket's Mewtwo ex at $445.87 is 1.03 Destined Rivals booster boxes. Lillie's Clefairy ex at $101.93 is 0.43 of a Journey Together one. That is what a higher chase value actually buys you, and it is also the risk: the Destined Rivals index moves when one card moves, because Team Rocket's Mewtwo ex is 25.5% of the set by itself.
Set value is the sum of the market price of every card we track in a set. Both sets qualify for release-date analysis because our series begins before each set's release, so the catalog was complete when the measurement window opened. All launch figures use the first reading dated on or after the published release date, never the first reading in the series, which for both sets is a pre-release stub. Slice values are derived from the recorded top-five and top-ten concentration ratios applied to set value; the five top cards listed individually sum to $1,020.48 against $1,020.64 derived, a 0.02% difference from rounding. Set indices are as of September 17, 2026. Card-level moves cover the 22 days ending September 20, 2026 and only lines priced at $1 or more on the first of those days; two lines have no catalog entry and are counted but not named. Sealed figures are current listing prices with their own 30-day change, not sold comps. Nothing here is investment advice.


